Ongoing Research Projects

ARCoV-005

A Global, Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Protective Efficacy, Safety and Immunogenicity of SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine in Population Aged 18 Years and Older

Proxalutamide

A Randomized, Double-blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Monovalent BA 4/5 Fase 1,2/3

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS- CoV-2 Variant (BA.4/5) mRNA Vaccine (ABO1020) in Healthy Subjects Aged 18 Years and Older Who Have Completed the Full Vaccination

M72 TB Vaccine

A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered intramuscularly on a 0,1-month schedule to adolescents and adults

RECOGNISE

Real-world effectiveness of ChAdOx-1s, CoronaVac, BBIBP CorV, mRNA-1273, and BNT162b2 in Jakarta: test-negative design study based in existing health care data sources

Monovalent Phase-1

A Randomized, Double-Blind, and Placebo-Controlled Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant mRNA Vaccines (ABO1009-DP and ABO-CoV.617.2) in Indonesian Subjects Aged 18 Years and Older Who Have Not Received SARS-CoV-2 Vaccines

IGRA Epid Study

Epidemiological study to assess IGRA positivity in a population with a high TB ​​burden

PREATTRI

Pretreatment Attrition in People with Drug-Resistant Tuberculosis

Randomized, open-label clinical trial to evaluate the safety and tolerability of viral-vector based Tuberculosis (TB) vaccine (Ad5- 105K) in healthy people aged 18 years to 59 years

Vax TB Inhale Phase-1

Randomized, observer-blind study to evaluate the safety and immunogenicity of a viral vector-based Tuberculosis (TB) vaccine (Ad5-105K) in healthy people aged 6 years and above

Vax TB Inhale Phase-2

The Usage of Rifapentine, Isoniazid, Pyrazinamide, and Moxifloxacin Combination for 4 months for Drug-Sensitive Tuberculosis Patients in Indonesia

C-TST

Operational research for evaluating the clinical diagnostic accuracy and patient acceptance of EC-TST in Indonesian population

PRIMA-4TB

A Randomized Trial Comparing Treatment Completion of Daily Rifapentine & Isoniazid for One Month (1HP) to Weekly Rifapentine & Isoniazid for 3 Months (3HP) in Persons Living with HIV and in HIV-Negative Household Contacts of Recently Diagnosed Tuberculosis Patients

Pneumococcal Invasive

Clinical Characteristics and Serotype Distribution in Patient Hospitalized with Invasive Pneumococcal Disease

1 to 3

BGSI

Human Genomic Analysis and Mycobacterium Tuberculosis in Cases of Drug-Sensitive and Drug-Resistant Pulmonary TB in Indonesia

Tongue Swab

Evaluating next generation LAM assays and molecular diagnostics (near POC and low complexity NAATs) for the diagnosis of TB among people with presumptive TB: a prospective multicentre diagnostic accuracy study

A Pulmonary Tuberculosis Prediction Using CAD4TB Artificial Intelligence (Computer-Aided Detection for Tuberculosis) Based on Thoracic X-Ray Photos among Indonesian Subjects

Vit C Zinc

Effectiveness of Vitamin C and Zinc as Adjuvant Therapy for Tuberculosis on MTB Culture Conversion

RAIT Study

TRUST-INA

Truncate Strategy for Drug-sensitive Tuberculosis in Indonesia